Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP

Abstract

Our results though hampered by the limited number of patients and the lack of a control group suggest AHSCT to be efficacious in therapy-refractory CIDP, with a manageable complication profile. Confirmation of these results is necessary through randomised controlled trials.